Adjuvant Therapy Benefit Estimator
Use this educational tool to estimate how adjuvant treatment options may change 10-year recurrence and mortality risk for early breast cancer.
What is an adjuvant online calculator?
An adjuvant online calculator is a decision-support tool that estimates the potential benefit of treatment given after surgery (adjuvant therapy). In breast cancer care, adjuvant therapies can include endocrine therapy, chemotherapy, HER2-targeted therapy, and radiation. These tools typically use patient and tumor features to estimate outcomes such as recurrence risk and breast cancer mortality.
Many people search for “adjuvant online calculator” because the original Adjuvant! Online resource is no longer widely available. Modern alternatives exist, but clinicians often combine multiple sources: validated prediction models, pathology, genomic assays, and patient preferences.
How this calculator works
This page provides a practical educational estimator. It is designed to help you understand core concepts:
- How baseline risk can change based on tumor size, nodal status, grade, and biomarkers.
- The difference between relative risk reduction and absolute benefit.
- Why treatment combinations can produce meaningful cumulative benefit.
The output reports estimated 10-year recurrence risk and estimated 10-year breast cancer mortality risk with and without selected adjuvant therapies.
Inputs explained
1) Clinical baseline factors
- Age: age can influence both tumor biology and treatment tolerance.
- Tumor size: larger primary tumors generally carry higher recurrence risk.
- Positive lymph nodes: nodal involvement is one of the strongest risk indicators.
- Tumor grade: grade reflects how aggressive the tumor appears microscopically.
- ER/HER2 status: these biomarkers strongly influence likely treatment response.
2) Treatment options
- Endocrine therapy: most helpful when ER is positive.
- Chemotherapy: benefit varies by subtype and baseline risk.
- Anti-HER2 therapy: intended for HER2-positive disease.
- Radiation therapy: mainly reduces local-regional recurrence and can modestly impact long-term outcomes.
How to use the calculator step by step
- Enter age, tumor size, node count, grade, ER status, and HER2 status.
- Select any adjuvant treatments being considered.
- Click Calculate Estimate.
- Review baseline risk, post-treatment risk, and absolute benefit.
- Use the estimate as a discussion aid with your oncology team.
Understanding the results
Absolute benefit vs relative benefit
Relative reductions can sound large, but absolute benefit is what usually matters most for decision-making. Example: a 30% relative reduction means very different things if baseline risk is 10% (absolute benefit 3%) versus 40% (absolute benefit 12%).
Risk categories
The calculator labels baseline recurrence risk as low, intermediate, or high to make interpretation easier. These categories are general educational bands, not treatment directives.
Important limitations
- This estimator is not a validated medical device and does not replace professional judgment.
- It does not include genomic signatures, menopausal status, PR status, treatment dose intensity, surgical margins, or all comorbidity details.
- Real-world outcomes vary by adherence, toxicity, and individual tumor biology.
If you are making actual treatment decisions, ask your care team about validated tools such as PREDICT and guideline-based models, and discuss whether genomic testing is appropriate in your case.
Frequently asked questions
Is this the original Adjuvant! Online?
No. This page is an independent educational replica-style calculator inspired by the same decision-support concept.
Can I use this result to choose therapy by myself?
No. Use it to prepare better questions for your oncologist, not to self-prescribe or decline treatment without clinical advice.
Why does anti-HER2 therapy disable when HER2 is negative?
Because HER2-targeted treatment is intended for HER2-positive disease; enabling it in HER2-negative settings would be misleading.
Bottom line
A good adjuvant calculator can make complex treatment tradeoffs easier to understand. The best use is shared decision-making: combine model estimates with your pathology, personal priorities, side-effect tolerance, and oncologist recommendations.